Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents
出版年份 2017 全文链接
标题
Carboxylate derivatives of tributyltin (IV) complexes as anticancer and antileishmanial agents
作者
关键词
Organotin (IV), Anticancer, Antileishmanial, ADMET, Protein kinase inhibition
出版物
DARU-Journal of Pharmaceutical Sciences
Volume 25, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-05
DOI
10.1186/s40199-017-0174-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
- (2016) Antoine Daina et al. ChemMedChem
- Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts
- (2016) Lisa Fish et al. GENES & DEVELOPMENT
- The Role of Nitric Oxide and Reactive Oxygen Species in the Killing of Leishmania braziliensis by Monocytes from Patients with Cutaneous Leishmaniasis
- (2016) Pedro Paulo Carneiro et al. PLoS One
- Extraction optimization of medicinally important metabolites from Datura innoxia Mill.: an in vitro biological and phytochemical investigation
- (2015) Humaira Fatima et al. BMC Complementary and Alternative Medicine
- Targeting cancer with kinase inhibitors
- (2015) Stefan Gross et al. JOURNAL OF CLINICAL INVESTIGATION
- Organometallic Compounds in Cancer Therapy: Past Lessons and Future Directions
- (2014) Pedro Martins et al. Anti-Cancer Agents in Medicinal Chemistry
- Synthesis, Characterization, Semiempirical and Biological Activities of Organotin(IV) Carboxylates with 4-Piperidinecarboxylic Acid
- (2014) Shabbir Hussain et al. BIOINORGANIC CHEMISTRY AND APPLICATIONS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PEGylated silver doped zinc oxide nanoparticles as novel photosensitizers for photodynamic therapy against Leishmania
- (2014) Akhtar Nadhman et al. FREE RADICAL BIOLOGY AND MEDICINE
- iLOGP: A Simple, Robust, and Efficient Description of n-Octanol/Water Partition Coefficient for Drug Design Using the GB/SA Approach
- (2014) Antoine Daina et al. Journal of Chemical Information and Modeling
- SwissTargetPrediction: a web server for target prediction of bioactive small molecules
- (2014) David Gfeller et al. NUCLEIC ACIDS RESEARCH
- Organotin(iv) carboxylate derivatives as a new addition to anticancer and antileishmanial agents: design, physicochemical characterization and interaction with Salmon sperm DNA
- (2014) Muhammad Sirajuddin et al. RSC Advances
- Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues
- (2014) Makiko Kawaguchi et al. Cancers
- Leishmaniasis: Current status of available drugs and new potential drug targets
- (2012) Nisha Singh et al. Asian Pacific Journal of Tropical Medicine
- Study of the Anticancer Properties of Tin(IV) Carboxylate Complexes on a Panel of Human Tumor Cell Lines
- (2011) Lourdes Rocamora-Reverte et al. ChemMedChem
- Sodium azide as a specific quencher of singlet oxygen during chemiluminescent detection by luminol and Cypridina luciferin analogues
- (2011) Martina Bancirova LUMINESCENCE
- Granzymes in cancer and immunity
- (2010) S P Cullen et al. CELL DEATH AND DIFFERENTIATION
- Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death
- (2010) C. van Noord et al. HEART
- In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences
- (2009) M. Vermeersch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmania majorMPK7 Protein Kinase Activity Inhibits Intracellular Growth of the Pathogenic Amastigote Stage
- (2009) Miguel A. Morales et al. EUKARYOTIC CELL
- 6-Br-5methylindirubin-3′oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: Exploitation of GSK-3 for treating leishmaniasis
- (2009) Evangelia Xingi et al. INTERNATIONAL JOURNAL FOR PARASITOLOGY
- Platinum neurotoxicity pharmacogenetics
- (2009) S. R. McWhinney et al. MOLECULAR CANCER THERAPEUTICS
- Pentavalent Antimonials: New Perspectives for Old Drugs
- (2009) Frédéric Frézard et al. MOLECULES
- Assessing drug-likeness – what are we missing?
- (2008) Giulio Vistoli et al. DRUG DISCOVERY TODAY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started